These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8222486

  • 1. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ, Glass M, Minkwitz MC.
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
    Smith LJ, Geller S, Ebright L, Glass M, Thyrum PT.
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
    [Abstract] [Full Text] [Related]

  • 3. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
    Dahlén B, Zetterström O, Björck T, Dahlén SE.
    Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986
    [Abstract] [Full Text] [Related]

  • 4. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT.
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
    Findlay SR, Barden JM, Easley CB, Glass M.
    J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
    Spector SL, Smith LJ, Glass M.
    Am J Respir Crit Care Med; 1994 Sep; 150(3):618-23. PubMed ID: 8087328
    [Abstract] [Full Text] [Related]

  • 12. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK, Lau LC, Thomson HW, Binks SM, Holgate ST.
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [Abstract] [Full Text] [Related]

  • 13. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I, Reiss TF, Rochette F, Botto A, Zhang J, Kundu S, Decramer M.
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [Abstract] [Full Text] [Related]

  • 14. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC, Georgiou P, Howland K, Dennis M, Compton CH, Barnes NC.
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [Abstract] [Full Text] [Related]

  • 15. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
    Lazarus SC, Wong HH, Watts MJ, Boushey HA, Lavins BJ, Minkwitz MC.
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
    [Abstract] [Full Text] [Related]

  • 16. The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.
    Donnelly AL, Glass M, Minkwitz MC, Casale TB.
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1734-9. PubMed ID: 7767514
    [Abstract] [Full Text] [Related]

  • 17. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
    Frølund L, Madsen F, Nielsen J.
    Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658
    [Abstract] [Full Text] [Related]

  • 18. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics.
    Joos GF, Kips JC, Pauwels RA, Van der Straeten ME.
    Pulm Pharmacol; 1991 Jul; 4(1):37-42. PubMed ID: 1804493
    [Abstract] [Full Text] [Related]

  • 19. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
    Finnerty JP, Wood-Baker R, Thomson H, Holgate ST.
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
    [Abstract] [Full Text] [Related]

  • 20. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
    Hui KP, Barnes NC.
    Lancet; 1991 May 04; 337(8749):1062-3. PubMed ID: 1673495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.